ClinicalTrials.gg
RecruitingNCT07230002NAVIGOUpdated Sep 17, 2026

Effects of Moderate/Severe Traumatic Brain Injury in the Subacute or Chronic Phase on Locomotor Strategies Involved in Navigation in Complex Virtual Environments

An interventional study of Locomotion in a virtual reality setting in Traumatic Brain Injury, sponsored by Pôle Saint Hélier. Recruiting at 1 site in France. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Pôle Saint Hélier · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 98 studies in Brain Injuries, Traumatic with a site in France — 23 open to participants now, 25 under way, 2 of them phase 3. Brain Injuries, Traumatic · France.

Planned enrollment
38th of 66
40 · median 55
Started
2027
the only one that year
No phase
40 of 98
8 open now
Primary completion
2028-02
later than 15 of 24 live
Registered
93rd of 98
by date

Among the 98 studies in Brain Injuries, Traumatic with a site in France, this one is the 38th largest by planned enrollment of the 66 interventional ones that give a count, is the only one that started in 2027, is one of 40 with no phase, reaches primary completion later than 15 of the 24 other live ones, and was the 93rd registered.

Brain Injuries, Traumatic

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

23 of the 98 studies in Brain Injuries, Traumatic with a site in France are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.

This study: 18 Years to 55 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 98 studies in Brain Injuries, Traumatic with a site in France, or all of them as a file.
02

Study summary

While clinical assessment of locomotor function in this population is carried out using tasks involving walking in a straight line without any obstacles, it does not take into account ecological situations (i.e., situations comparable to real-life situations) in which the person interacts with their environment, such as walking down a street with other pedestrians, which is fundamental to everyday life. This research therefore aims to study the social navigation skills during locomotion of people who have suffered a moderate or severe head injury in the chronic phase in more ecological tasks. This will provide a better understanding of the difficulties encountered by these patients during locomotor interactions in everyday life.

03

Conditions studied

  • Traumatic Brain Injury
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria for Traumatic Brain Injury group :

  • 18 ≤ Age ≤ 55 years old
  • Male/female
  • Having suffered a first non-penetrating head injury
  • Moderate to severe severity with initial Glasgow Coma Scale score 5\<GCS\<13
  • In the subacute or chronic phase (≥ 3 months at the date of the experiment, relative to the date of the injury)
  • Able to walk (10WMT speed ≥ 0.8 m/s, able to walk at least 20 m without technical or human assistance, PM ≥ 300 m)
  • Able to maintain dynamic balance while standing (TUG\<16s)
  • Able to answer simple questionnaires, according to the investigator's judgment
  • Having given their free, informed, expressed (written) consent
  • Registered with a social security system
  • Individuals under legal protection measures such as guardianship may be eligible

Inclusion Criteria for healthy control group :

  • 18 ≤ Age ≤ 55 years old
  • Male/female
  • Able to walk (≥ 0.8 m/s, able to walk at least 20 m without technical or human assistance, PM ≥ 300 m)
  • Able to answer simple questionnaires, according to the investigator's judgment
  • Having given free, informed, expressed (written) consent
  • Registered with a social security system

Exclusion Criteria specific to patients in the traumatic brain injury group :

- Person under legal protection (excluding guardianship) or unable to express consent

Exclusion Criteria for both groups :

  • Severe patho-psychiatric care underway, which may impact the conduct of the protocol, at the investigator's discretion
  • Presence of neurological signs suggestive of a neurodegenerative disease responsible for gait disturbance (Parkinson's syndrome, Alzheimer's disease, etc.)
  • Individuals with musculoskeletal disorders that impact their locomotor abilities
  • Presence of uncontrolled epilepsy at the time of inclusion
  • Presence of visual impairments that make experimentation impossible, at the discretion of the investigator
  • Pregnant, parturient, or breastfeeding women
  • Participants in another ongoing research protocol involving human subjects

Exclusion Criteria for healthy control group :

  • Presence of fatigue, trauma, or a condition affecting mobility, posture, balance, or walking
  • Persons deprived of their liberty by a judicial or administrative decision
  • Persons deprived of their liberty by judicial or administrative decision
  • Persons under legal protection (guardianship, curatorship, judicial protection) or unable to express their consent
  • Persons undergoing severe psychiatric treatment or admitted to a health or social care facility for purposes other than research.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Single group

    Patients as well as healthy participants will be asked to perform several exercises under virtual reality conditions. Questionnaires and scales will also be completed by the participants.

    Other: Locomotion in a virtual reality setting

Interventions

  • OtherLocomotion in a virtual reality setting

    Patients and participants will be asked to perform several walking/locomotion tasks in a virtual evironment setting. The setting in question is a concert in a parc. The participants will have to walk towards the stage whilst avoiding bumping into "virtual people". A total of 5 different tasks (walking in a straight line, walking between people etc) will be completed for each participant. Different variables will then be recorded and extracted such as walking speed, interpersonnal distances, eye fixation times.

06

What researchers measure

Primary outcomes

  1. Perceptive dimension : Elements of the environment viewed : Distribution (in %)

    Time frame: From enrollment to the end of the participation at maximum 30 days

  2. Perceptive dimension : Elements of the environment viewed : Distance (in meters)

    Time frame: From enrollment to the end of the participation at maximum 30 days

  3. Perceptive dimension : Elements of the environment viewed : duration of fixations (in milliseconds)

    Time frame: From enrollment to the end of the participation at maximum 30 days

  4. Cognitive dimension : characteristics of the path taken : length of the path taken (in meters)

    Time frame: From enrollment to the end of the participation at maximum 30 days

  5. Cognitive dimension : characteristics of the path taken : interpersonal distances with virtual humans (in m)

    Time frame: From enrollment to the end of the participation at maximum 30 days

  6. Action-related dimension : walking speed (measured in m/s)

    Time frame: From enrollment to the end of the participation at maximum 30 days

Secondary outcomes

  1. " Montréal Cognitive Assesment " (MoCA)

    Time frame: On day 1

  2. " 10-Meter Walking Test " (10MWT)

    Time frame: At day 1

  3. Balance test : ABC-scale

    Time frame: At day 1

  4. Balance test : "Berg Balance Scale" (BBS)

    Balance test: Berg Balance Scale (BBS), 14-item scale with a total score ranging from 0 (worst balance) to 56 (best balance); higher scores indicate better balance.

    Time frame: At day 1

  5. Balance test : "Time Up and Go" (TUG)

    Balance test: Timed Up and Go (TUG), time to complete the test measured in seconds; lower times indicate better functional mobility and balance, whereas longer times indicate poorer mobility and increased fall risk.

    Time frame: At day 1

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Feb 2028, 13 months later.

Of 445 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 64. This study's planned 13 months is below that.

Counting every sponsor, half of 467 studies reached it within 41 months; a quarter within 22 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2025
First posted
Nov 17, 2025
StartEst.
Jan 4, 2027
Primary completionEst.
Feb 28, 2028
CompletionEst.
Feb 28, 2028
Last update
Sep 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07230002
Lead sponsor
Pôle Saint Hélier
Responsible party
Sponsor
First posted
Nov 17, 2025
Start date
Jan 4, 2027 (estimated)
Primary completion
Feb 28, 2028 (estimated)
Completion
Feb 28, 2028 (estimated)
Last update
Sep 17, 2026

Study contacts

Emilie Leblong, MD
Contact
emilie.leblong@fondationsainthelier.com
+33299295043

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion